Contrasting Glycemic Outcomes in Young People with Diabetic Ketoacidosis at Onset of Type 1 Diabetes
Diabetes Technology & Therapeutics · 2024
DOI: 10.1089/dia.2024.0147 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes Technology & Therapeutics, 2024. Verfasst von Rama Lakshman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Diabetes Mellitus, Type 1, Blood Glucose. Die Arbeit nennt 3 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom.
- Department of Paediatrics, University of Cambridge, Cambridge, United Kingdom.
- Wolfson Diabetes and Endocrine Clinic, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
ORCID-Profile: Rama Lakshman, Charlotte K Boughton
Zitieren
APA
Lakshman, R., Najami, M., Hovorka, R., & Boughton, C. K. (2024). Contrasting Glycemic Outcomes in Young People with Diabetic Ketoacidosis at Onset of Type 1 Diabetes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0147
Vancouver
Lakshman R, Najami M, Hovorka R, Boughton CK. Contrasting Glycemic Outcomes in Young People with Diabetic Ketoacidosis at Onset of Type 1 Diabetes. Diabetes Technology & Therapeutics. 2024. doi:10.1089/dia.2024.0147
BibTeX
@article{Lakshman2024,
author = {Lakshman, Rama and Najami, Mazin and Hovorka, Roman and Boughton, Charlotte K},
title = {Contrasting Glycemic Outcomes in Young People with Diabetic Ketoacidosis at Onset of Type 1 Diabetes},
journal = {Diabetes Technology & Therapeutics},
year = {2024},
doi = {10.1089/dia.2024.0147}
}
EUVIMED